Associate Professor of Pediatrics, University Wash
Pediatric Hematology & Oncology
Dr. Douglas S. Hawkins, MD
|
|
Give Review
Douglas Hawkins works in the field of Pediatric Hematology & Oncology. He over the years received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top MD" and "Super Doctor". Douglas Hawkins is a published physician. He published 79 publications, including: 'Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: AReport From the Children's Oncology Group.'
Publications
- Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
- Intensive Multiagent Therapy, including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Pati...
- Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?
- Clonality and evolutionary history of rhabdomyosarcoma.
- Family history of Cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.
- Assessing the scale of tumor heterogeneity by complete hierarchical segmentation of MRI.
- Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.
- Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology...
- Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative Tumors.
- What is new in the biology and treatment of pediatric rhabdomyosarcoma?
- Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: A report from the Children's Oncology Group.
- Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children's Onco...
- Targeting oxidative stress in embryonal rhabdomyosarcoma.
- The Effect of Radiation Timing on Patients With High-Risk Features of Parameningeal Rhabdomyosarcoma: An Analysis of IRS-IV and D9803.
- A novel algorithm for simplification of complex gene classifiers in Cancer.
- Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group S...
- Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's...
- Allergies, atopy, Immune-related factors and childhood rhabdomyosarcoma: A report from the children's oncology group.
- PAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children's Oncology Group Report.
- Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997:...
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.
- An evaluation of F-18-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing Sarcoma.
- (18) F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.
- Local Control with Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group D9602 Study.
- The clinical, research, and social value of autopsy after any Cancer death: A perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee.
- Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation: in vitro and in vivo investigations.
- Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
- Minimal residual Disease detected prior to hematopoietic cell transplantation.
- Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma ...
- Sarcomas gone bad: What to do about recurrent Ewing sarcoma.
- Ewing sarcoma/primitive neuroectodermal tumor arising from the Adrenal gland in an adolescent.
- Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is Amputation Necessary? A Report From the Children's Oncology Group.
- Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized Osteosarcoma: A report from the Children's Oncology Group.
- Prognostic significance and tumor biology of regional lymph node Disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
- Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.
- (18)F-FDG PET in sarcoma treatment response imaging.
- Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the children's oncology group.
- Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the C...
- Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.
- Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.
- Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on Disease-free survival and immunomodulation. a repor...
- Regional Nodal Involvement and Patterns of Spread Along In-transit Pathways in Children With Rhabdomyosarcoma of the Extremity: A Report From the Children's Oncology G...
- No evidence of a trial effect in newly diagnosed pediatric Acute lymphoblastic leukemia.
- Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas.
- Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphami...
- Pegfilgrastim for prevention of chemotherapy-associated neutropenia in pediatric patients with solid Tumors.
- Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group.
- [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity Osteosarcoma in children and young adults.
- COX-2 expression correlates with survival in patients with osteosarcoma Lung metastases.
- Two boys with fragile x syndrome and hepatic Tumors.
- Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarco...
- Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/Leukemia.
- Pediatric intradural extramedullary synovial sarcoma: case report.
- Topotecan by 21-day continuous infusion in children with relapsed or refractory solid Tumors: a Children's Oncology Group study.
- Oral outpatient chemotherapy medication errors in children with Acute lymphoblastic leukemia.
- Survival of tumor megaprostheses replacements about the knee.
- [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of Tumors.
- Phase II trial of oral aminopterin for adults and children with refractory Acute leukemia.
- Fas expression in Lung metastasis from osteosarcoma patients.
- Survival after recurrence of Ewing's sarcoma family of Tumors.
- Metastatic Malignant melanoma presenting as pancytopenia in a three-year-old boy.
- Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
- Transatlantic collaboration in pediatric oncology: now is the time.
- Toxicity and efficacy of intensive chemotherapy for children with Acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
- Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed Acute lymphoblastic leukemia.
- Influence of age upon Ifosfamide-induced nephrotoxicity.
- Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
- Evaluation of early marrow response in childhood aneuploid Acute lymphoblastic leukemia: flow cytometric DNA analysis versus standard morphology.
- Pattern of Disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
- Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
- Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.
- Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
- Treatment of metastatic Osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels.
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.
- Ganglioside GD2 expression is maintained upon recurrence in patients with Osteosarcoma.
- Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
- Malignant progression in two children with multiple osteochondromas.
- Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual Disease...
Schools
Harvard Medical School
University Of Wa School Of Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top MD
- Super Doctor
Education
-
University of Washington
Hospital
-
Seattle Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jenny W. Pang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey R. Geyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandon K. Hadland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen S. Delaney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana C. Matthews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara E. Small, MD |
|
|
Dr. Ronald S. Cheung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Manley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie Bleakley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blythe Thomson, MD
This Doctor is OpenDoctor Recommended.
|